Neoadjuvante versus definitive Radiochemotherapie des lokoregionär fortgeschrittenen Ösophaguskarzinoms : wer profitiert?
Preview
Cite
Access Statistic

Rights
Use and reproduction:
All rights reserved
Use and reproduction:
All rights reserved